Annovis Bio, Inc. - Common Stock, par value $0.0001 per share (ANVS)
CUSIP: 03615A108
Q1 2021 13F Holders as of 31 Mar 2021
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 19,607,843
- Total 13F shares
- 834,363
- Share change
- +73,452
- Total reported value
- $23,108,000
- Price per share
- $27.90
- Number of holders
- 29
- Value change
- +$2,874,108
- Number of buys
- 19
- Number of sells
- 9
Quarterly Holders Quick Answers
What is CUSIP 03615A108?
CUSIP 03615A108 identifies ANVS - Annovis Bio, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 03615A108:
Top shareholders of ANVS - Annovis Bio, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| AIGH Capital Management LLC |
13F
|
Company |
2.4%
|
463,797
|
$3,497,000 | — | 31 Dec 2020 | |
| Worth Venture Partners, LLC |
13F
|
Company |
0.61%
|
119,538
|
$901,000 | — | 31 Dec 2020 | |
| Sterling Investment Advisors, Ltd. |
13F
|
Company |
0.26%
|
50,588
|
$381,000 | — | 31 Dec 2020 | |
| Modera Wealth Management, LLC |
13F
|
Company |
0.22%
|
43,846
|
$331,000 | — | 31 Dec 2020 | |
| Lokken Investment Group LLC |
13F
|
Company |
0.16%
|
32,211
|
$243,000 | — | 31 Dec 2020 | |
| BROWN ADVISORY INC |
13F
|
Company |
0.08%
|
14,942
|
$113,000 | — | 31 Dec 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.07%
|
14,286
|
$108,000 | — | 31 Dec 2020 | |
| Cannell & Co. |
13F
|
Company |
0.05%
|
10,000
|
$75,000 | — | 31 Dec 2020 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.04%
|
7,396
|
$56,000 | — | 31 Dec 2020 | |
| Sowell Financial Services LLC |
13F
|
Company |
0.01%
|
1,529
|
$12,000 | — | 31 Dec 2020 | |
| Rockefeller Capital Management L.P. |
13F
|
Company |
0.01%
|
1,000
|
$7,000 | — | 31 Dec 2020 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
778
|
$6,000 | — | 31 Dec 2020 |
Institutional Holders of Annovis Bio, Inc. - Common Stock, par value $0.0001 per share (ANVS) as of Q1 2021
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2021 vs Q4 2020 Across Filers
| Investor | Q4 2020 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q4 2020 Value $ | Q1 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.